Substance | Condition | Seq | Src | PMID | Dtl | Title |
Citicoline | Alzheimer's Disease | 6 | PM | 38136170 | 📋 | Memory Recovery Effect of a New Bioactive Innovative Combination in Rats with Experimental Dementia |
Citicoline | Alzheimer's Disease | 2 | PM | 34870911 | 📋 | [Citicoline in the treatment of cognitive impairment in first-degree relatives of AD patients: the influence of the ApoE genotype] |
Citicoline | Alzheimer's Disease | 1 | PM | 33459645 | 📋 | A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease |
Citicoline | Alzheimer's Disease | 3 | PM | 32538854 | 📋 | Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review |
Citicoline | Alzheimer's Disease | 4 | PM | 32447126 | 📋 | The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia |
Citicoline | Alzheimer's Disease | 5 | PM | 28035929 | 📋 | The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study |
Citicoline | Multiple Sclerosis | 2 | PM | 34832936 | 📋 | Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination |
Citicoline | Multiple Sclerosis | 1 | PM | 33918331 | 📋 | Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis |
Citicoline | Multiple Sclerosis | 3 | PM | 25524711 | 📋 | Pivotal role of choline metabolites in remyelination |
Citicoline | Neurodegenerative Disease | 1 | PM | 34184483 | 📋 | [Molecular and clinical aspects of the effect of cytidyndiphosphocholine on cognitive functions] |
Citicoline | Neurodegenerative Disease | 2 | PM | 24736780 | 📋 | Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration |
Citicoline | Parkinson's Disease | 1 | PM | 33279231 | 📋 | Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review |
Citicoline | Parkinson's Disease | 2 | PM | 28805762 | 📋 | [A study of combination treatment with nacom (levodopa + carbodope) and citicoline in the model of Parkinson disease in rats] |